Your browser doesn't support javascript.
loading
[Diagnosis and treatment of pancreatic head cancer followed by mesenteric-portal vein invasion]. / Diagnostika i lechenie raka golovki podzheludochnoi zhelezy, prorastaiushchego mezenteriko-portal'nyi segment ven.
Kriger, A G; Karmazanovsky, G G; Smirnov, A V; Kharazov, A F; Gorin, D S; Raevskaya, M B; Galkin, G V; Revishvili, A Sh.
Affiliation
  • Kriger AG; Vishnevsky National Medical Research Center of Surgery of Healthcare Ministry of Russia, Moscow, Russia.
  • Karmazanovsky GG; Vishnevsky National Medical Research Center of Surgery of Healthcare Ministry of Russia, Moscow, Russia.
  • Smirnov AV; Vishnevsky National Medical Research Center of Surgery of Healthcare Ministry of Russia, Moscow, Russia.
  • Kharazov AF; Vishnevsky National Medical Research Center of Surgery of Healthcare Ministry of Russia, Moscow, Russia.
  • Gorin DS; Vishnevsky National Medical Research Center of Surgery of Healthcare Ministry of Russia, Moscow, Russia.
  • Raevskaya MB; Vishnevsky National Medical Research Center of Surgery of Healthcare Ministry of Russia, Moscow, Russia.
  • Galkin GV; Vishnevsky National Medical Research Center of Surgery of Healthcare Ministry of Russia, Moscow, Russia.
  • Revishvili AS; Vishnevsky National Medical Research Center of Surgery of Healthcare Ministry of Russia, Moscow, Russia.
Khirurgiia (Mosk) ; (12): 21-29, 2018.
Article in Ru | MEDLINE | ID: mdl-30560841
ABSTRACT

AIM:

To evaluate the outcomes of pancreaticoduodenectomy with mesenteric-portal vein resection for pancreatic head cancer. MATERIAL AND

METHODS:

Retrospective analysis included 124 patients with pancreatic head cancer for the period 2010-2017. Mesenteric-portal vein (MPV) invasion was diagnosed in 37 (29.8%) patients, tumor contact with superior mesenteric artery as a borderline resectable state was noted in 11 cases. All patients underwent pancreaticoduodenectomy with mesenteric-portal vein resection.

RESULTS:

Vein invasion was histologically confirmed in 19 (51.3%) out of 37 patients. At the same time, arterial invasion was absent in 11 patients with a borderline resectable tumor. CT-associated overdiagnosis of venous wall invasion was 6.4%, intraoperative overdiagnosis - 87.5%. R0-resection was achieved in 88.5% after conventional pancreaticoduodenectomy and in 78.4% after pancreaticoduodenectomy followed by MPV resection. Median survival was 17 months, 2-year survival - 41%. Among 11 patients with a borderline resectable tumor median survival was 11 months. Pancreaticoduodenectomy without vein resection was followed by 2-year survival near 68.1%. Differences were significant (p=0.02).

CONCLUSION:

Pancreaticoduodenectomy followed by MPV resection as the first stage of combined treatment of pancreatic head cancer is absolutely justified if circumferential involvement of the vein and contact with superior mesenteric artery or celiac trunk do not exceed 50%. Vein resection can provide R0-surgery in these cases.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Portal Vein / Pancreaticoduodenectomy / Mesenteric Veins Type of study: Diagnostic_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: Ru Journal: Khirurgiia (Mosk) Year: 2018 Document type: Article Affiliation country: Rusia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Portal Vein / Pancreaticoduodenectomy / Mesenteric Veins Type of study: Diagnostic_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: Ru Journal: Khirurgiia (Mosk) Year: 2018 Document type: Article Affiliation country: Rusia
...